Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health & Wellness Today New York.
Press releases published on June 25, 2025
June is Acne Awareness Month – Dr. Navin Arora of Borealis Dermatology Shines Light on Hopeful Advances
EIN Presswire
·
June 25, 2025
Dr. Navin Arora is committed to educating individuals about the causes of acne, the range of treatment options, and the emotional toll it can take. GARDEN CITY, NY, UNITED STATES, June 25, 2025 /EINPresswire.com/ -- June marks Acne Awareness Month, a …
‘Your Health in Full Bloom’ Health Expo Brings Health Education to Families and Their Communities
EIN Presswire
·
June 25, 2025
The Health and Wellness Expo, featuring a live panel discussion, empowers understanding of whole-body wellness for lives unrestricted by health challenges. NEW YORK, NY, UNITED STATES, June 25, 2025 /EINPresswire.com/ -- USA Clinics Group is proud to …
New Report Calls for Urgent Partnership: Cuts to Public Health Strain Health Care System, Drive Up Costs for Patients
EIN Presswire
·
June 25, 2025
A special report from the nonpartisan not-for-profit Common Health Coalition offers insights on the health care impacts of public health disinvestment NEW YORK, NY, UNITED STATES, June 25, 2025 /EINPresswire.com/ -- The Common Health Coalition has …
Black Talon Security Wins Pax8 Beyond Award for MVP Security, North America
EIN Presswire
·
June 25, 2025
A valued partnership enabling effective, affordable top-tier cybersecurity protection for all clients KATONAH, NY, UNITED STATES, June 25, 2025 /EINPresswire.com/ -- Black Talon Security today announced it has received the 2025 Pax8 Beyond Partner Award …
Sequretek Ensures Every Asset Matters with the Launch of Percept CTEM
EIN Presswire
·
June 25, 2025
NY, UNITED STATES, June 25, 2025 /EINPresswire.com/ -- Sequretek, a global leader in AI-powered cybersecurity solutions, today launched its latest SaaS innovation: Percept CTEM. This groundbreaking platform aims to eliminate surprises by offering …
Altimmune to Announce Topline 24 Week Results from its IMPACT Phase 2b Trial of Pemvidutide in the Treatment of MASH on Thursday, June 26
GlobeNewswire
·
June 25, 2025
GAITHERSBURG, Md., June 25, 2025 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a late clinical-stage biopharmaceutical company developing novel peptide-based therapeutics for liver and cardiometabolic diseases, will host an investor webcast on …
Rakovina Therapeutics Announces Results from 2025 Annual General Meeting
GlobeNewswire
·
June 25, 2025
VANCOUVER, British Columbia, June 25, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO0) (“Rakovina” or the “Company”), a biopharmaceutical company advancing next-generation cancer therapies through artificial intelligence (AI)- …
Summer's Impact on the Blood Supply
GlobeNewswire
·
June 25, 2025
Davenport, Iowa, June 25, 2025 (GLOBE NEWSWIRE) -- ImpactLife is seeing the effect of summer vacation season on our region’s blood supply, and with the Fourth of July weekend just ahead, the blood center is now looking to add appointments and improve the …
Appili Therapeutics Reports Fiscal Year 2025 Financial and Operational Results
GlobeNewswire
·
June 25, 2025
LIKMEZ™ (ATI-1501) for Metronidazole Oral Suspension 500mg/5mL re-launched and commercial sales ongoing Five U.S. government proposals submitted, totalling up to US$125 million HALIFAX, Nova Scotia, June 25, 2025 (GLOBE NEWSWIRE) -- Appili Therapeutics …
Hapbee Announces CDN$1.5M Private Placement Led by Company Executive; Announces Appointment of Ahsan Ashraf as Chief Technology Officer
GlobeNewswire
·
June 25, 2025
VANCOUVER, British Columbia, June 25, 2025 (GLOBE NEWSWIRE) -- Hapbee Technologies, Inc. (TSXV: HAPB) (OTCQB: HAPBF) (FSE: HA1) (“Hapbee” or the “Company”), the digital wellness technology company, is pleased to announce a non-brokered private placement …
PSYENCE GROUP INC. Announces Update on Previously Announced Non-Brokered Private Placement of Common Shares
GlobeNewswire
·
June 25, 2025
TORONTO, June 25, 2025 (GLOBE NEWSWIRE) -- Psyence Group Inc. (CSE: PSYG) (“Psyence” or the “Company”), a life science biotechnology company pioneering the use of natural psilocybin in mental health and well-being, is pleased to announce an update to its …
Hapbee Issues Clarification of June 24, 2025 Press Release on Q1 2025 Financial Results
GlobeNewswire
·
June 25, 2025
VANCOUVER, British Columbia, June 25, 2025 (GLOBE NEWSWIRE) -- Hapbee Technologies Inc. (TSXV: HAPB | OTCQB: HAPBF), (“Hapbee” or the “Company”), the digital wellness technology company pioneering the science of bio-streaming, announces this clarification …
Vor Bio Announces $175 Million Private Placement
GlobeNewswire
·
June 25, 2025
CAMBRIDGE, Mass., June 25, 2025 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company transforming the treatment of autoimmune diseases, today announced that it has entered into a securities purchase agreement for a private …
Vor Bio Enters into Exclusive Global License Agreement with RemeGen for Late-Stage Autoimmune Asset
GlobeNewswire
·
June 25, 2025
-Vor Bio receives ex-Greater China rights to develop and commercialize telitacicept, a novel, dual-target recombinant fusion protein in global Phase 3 development for generalized myasthenia gravis -RemeGen receives initial payment of $125 million …
Main Results of 2025 Annual and Extraordinary General Meeting
GlobeNewswire
·
June 25, 2025
REYKJAVÍK, Iceland and LUXEMBOURG, June 25, 2025 (GLOBE NEWSWIRE) -- The 2025 Annual and Extraordinary General Meeting (the "2025 AGM") of Alvotech (the "Company") was held on June 25, 2025, at Arendt House, 41A Avenue John F. Kennedy, L-2082 Luxembourg, …
Coalition to Improve Access to Cancer Care Applauds Reintroduction of the Cancer Drug Parity Act
GlobeNewswire
·
June 25, 2025
WASHINGTON, June 25, 2025 (GLOBE NEWSWIRE) -- The Coalition to Improve Access to Cancer Care (CIACC) applauds the reintroduction of the Cancer Drug Parity Act, bipartisan legislation that would require group and individual health insurance plans to cover …
Teva to Host Conference Call to Discuss Second Quarter 2025 Financial Results at 8 a.m. ET on July 30, 2025
GlobeNewswire
·
June 25, 2025
TEL AVIV, Israel, June 25, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that it will issue a press release on its second quarter 2025 financial results on Wednesday, July 30, 2025, at 7:00 a.m. ET. …
Reviva Pharmaceuticals Holdings, Inc. Announces Proposed Public Offering
GlobeNewswire
·
June 25, 2025
CUPERTINO, Calif., June 25, 2025 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a late-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central …
DBV Technologies annonce le screening du premier sujet de l'étude complémentaire d’innocuité COMFORT Toddlers chez les enfants âgés de 1 à 3 ans allergiques à l’arachide.
GlobeNewswire
·
June 25, 2025
Châtillon, France, le 25 juin (22 :30 CEST) 2025 DBV Technologies annonce le screening du premier sujet de l'étude complémentaire d’innocuité COMFORT Toddlers chez les enfants âgés de 1 à 3 ans allergiques à l’arachide. Screening du premier sujet à l' …
DBV Technologies Announces First Subject Screened in COMFORT Toddlers Supplemental Safety Study in Peanut Allergic Toddlers 1 – 3 Years Old
GlobeNewswire
·
June 25, 2025
Châtillon, France, June 25, 2025 DBV Technologies Announces First Subject Screened in COMFORT Toddlers Supplemental Safety Study in Peanut Allergic Toddlers 1 – 3 Years Old First subject screened at the Respiratory Medicine Research Institute of Michigan …